/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

BIOMEA FUSION INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$1.07 0.0968(9.68%) BMEA at 04 Dec 2025 04:27 PM Biotechnology
Lowest Today 0.96525
Highest Today 1.07
Today’s Open 1
Prev. Close 0.9573
52 Week High 6.79
52 Week Low 0.87
Day’s Range: Low 0.96525 High 1.07
52-Week Range: Low 0.87 High 6.79
1 day return -
1 Week return -4.09
1 month return -16.26
3 month return -42.03
6 month return -62.72
1 year return -84.23
3 year return -84.25
5 year return -
10 year return -

Institutional Holdings

FMR Inc 12.17

Heights Capital Management Inc 6.45

Cormorant Asset Management, LLC 6.00

Fidelity Growth Compy Commingled Pl S 5.31

Fidelity Growth Company Fund 3.71

Aisling Capital Management LP 3.44

Vanguard Group Inc 3.16

Woodline Partners LP 2.93

Vanguard Total Stock Mkt Idx Inv 2.41

Blue Owl Capital Holdings LP 2.18

Fidelity Growth Company K6 1.31

BlackRock Inc 1.27

Fidelity Series Growth Company 1.12

Federated Hermes Inc 0.97

Federated Hermes MDT SCC Institutional 0.93

Federated Hermes MDT Small Cap Core IS 0.93

Adage Capital Partners Gp LLC 0.84

Millennium Management LLC 0.78

Fidelity Select Biotechnology 0.71

Morgan Stanley - Brokerage Accounts 0.65

Burkehill Global Management, LP 0.59

Two Sigma Investments LLC 0.59

AQR Capital Management LLC 0.57

Two Sigma Advisers, LLC 0.50

iShares Biotechnology ETF 0.50

Vanguard Institutional Extnd Mkt Idx Tr 0.46

Geode Capital Management, LLC 0.46

Scotia Capital Inc 0.43

SUPERSTRING CAPITAL MANAGEMENT LP 0.42

UBS Group AG 0.42

Fidelity Extended Market Index 0.23

Schwab US Small-Cap ETF™ 0.20

Bridgeway Ultra-Small Company Market 0.11

iShares Micro-Cap ETF 0.11

Fidelity Total Market Index 0.07

Extended Equity Market Fund K 0.07

Fidelity Series Total Market Index 0.06

Spartan Extended Market Index Pool F 0.05

Vanguard Balanced Index Inv 0.05

Northern Trust Extended Eq Market Idx 0.04

Market Status

Strong Buy: 4

Buy: 3

Hold: 2

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 67.68 M

PB Ratio 4.9342

PE Ratio 0.0

Enterprise Value 31.64 M

Total Assets 79.94 M

Volume 1602000

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-107685000 -107.7M, FY22:-80022000 -80.0M, FY21:-41218000 -41.2M, FY20:-5324000 -5.3M, FY19:-1198000 -1.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-500000 -0.5M, Q1/2025:null 0.0M, Q3/2024:-400000 -0.4M, Q2/2024:-400000 -0.4M

Quarterly Net worth Q3/2025:-16407000 -16.4M, Q2/2025:-20740000 -20.7M, Q1/2025:-29262000 -29.3M, Q3/2024:-32787000 -32.8M, Q2/2024:-37276000 -37.3M

Fund house & investment objective

Company Information Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.

Organisation Biotechnology

Employees 42

Industry Biotechnology

CEO Dr. Michael J. M. Hitchcock Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow